94977-60-3

Usage

Derivative of benzimidazole

Yes
A derivative is a compound that is structurally related to another compound, in this case, benzimidazole.

Bicyclic compound

Yes
The compound has two fused rings, a benzene ring and an imidazole ring.

Presence of a methyl group

2-position
The compound has a methyl group (CH3) attached to the 2nd position of the benzimidazole ring, making it a 2-methyl derivative.

Potential pharmaceutical applications

Yes
Due to its structural similarity to other benzimidazole derivatives with biological activity, it may have potential uses in the pharmaceutical industry.

Synthesis of other organic compounds

Yes
The compound may be used as a starting material or intermediate in the synthesis of other organic compounds.

Utility in medicinal chemistry

Yes
It may serve as a building block in the development of new drugs and therapeutic agents.

Further research needed

Yes
More research is required to fully understand the potential uses and properties of 1H-Benzimidazol-4-ol,2-methyl-(9CI).

Upstream product

• 59649-56-8 2,3-diaminophenol 
• 64-19-7 acetic acid 
• 116345-46-1 N-(2-Acetylamino-6-hydroxy-phenyl)-acetamide 
• 27077-75-4 4-methoxy-2-methyl-1H-benzo[d]imidazole 
• 37466-89-0 3-methoxybenzene-1,2-diamine 

Downstream Products

• 200799-06-0 4-(2,6-dimethylbenzyloxy)-2-methylbenzimidazole 
• 200799-10-6 4-(2,6-dimethyl-4-fluorobenzyloxy)-2-methylbenzimidazole 

Relevant academic research and scientific papers

VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS

Pyrimidine ethers and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.

Compositions for dyeing keratinous fiber

A composition for dyeing keratinous fiber which includes incorporated therein an oxidative color-developing substance, an enzyme which reacts with oxygen as a substrate but does not evolve hydrogen peroxide, and a weak reducing agent.

Derivatives of benzimidazoles active as anti-ulcer agents

Novel compounds of the general formula I STR1 processes for its preparation, pharmaceutical compositions containing such compounds as the active ingredient and the use of the compounds in medicine.